A Perspective on Covalent Hit Identification and Validation in the European Pharmaceutical Industry.

Schadt O, Essig S, Testolin G.

Open source

DOI
10.1002/cbic.70523
Published
2026-09-01
Container
Chembiochem
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cbic.70523,
  title = {A Perspective on Covalent Hit Identification and Validation in the European Pharmaceutical Industry.},
  author = {Schadt O and  Essig S and  Testolin G.},
  year = {2026},
  journal = {Chembiochem},
  doi = {10.1002/cbic.70523},
  url = {https://doi.org/10.1002/cbic.70523}
}

RIS

TY  - JOUR
TI  - A Perspective on Covalent Hit Identification and Validation in the European Pharmaceutical Industry.
AU  - Schadt O
AU  -  Essig S
AU  -  Testolin G.
PY  - 2026
JO  - Chembiochem
DO  - 10.1002/cbic.70523
UR  - https://doi.org/10.1002/cbic.70523
ER  - 

APA

O, S., S, E., & G., T. (2026). A Perspective on Covalent Hit Identification and Validation in the European Pharmaceutical Industry.. Chembiochem. https://doi.org/10.1002/cbic.70523

Source records